Clinical trials
Completed Motor Skills Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Ghent | 5 |
| Hacettepe University | 3 |
| Federal University of Minas Gerais | 2 |
| Hasselt University | 2 |
| Riphah International University | 2 |
| Shanghai University of Sport | 2 |
| Ankara University | 1 |
| Asir John Samuel | 1 |
| Cairo University | 1 |
| Central Michigan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Motor Skills Disorders | 54 |
| Cerebral Palsy | 7 |
| Attention Deficit Disorder with Hyperactivity | 3 |
| Autism Spectrum Disorder | 3 |
| Cognitive Dysfunction | 3 |
| Stroke | 3 |
| Brain Injuries | 2 |
| Neurodevelopmental Disorders | 2 |
| Premature Birth | 2 |
| Sensation Disorders | 2 |
Trials
Showing 76 to 54 of 54. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.